A disorder characterized by grinding and clenching of the teeth.
A sleep disorder characterized by grinding and clenching of the teeth and forceful lateral or protrusive jaw movements. Sleep bruxism may be associated with TOOTH INJURIES; TEMPOROMANDIBULAR JOINT DISORDERS; sleep disturbances; and other conditions.
A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.
Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS.
Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS.
A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes (sometimes called antigenic types, or strains) exist, each producing a different botulinum toxin (BOTULINUM TOXINS). The organism and its spores are widely distributed in nature.
Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)
Antiserum given therapeutically in BOTULISM.
Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.
An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.
A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)
Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.
A symptom, not a disease, of a twisted neck. In most instances, the head is tipped toward one side and the chin rotated toward the other. The involuntary muscle contractions in the neck region of patients with torticollis can be due to congenital defects, trauma, inflammation, tumors, and neurological or other factors.
Loss of the tooth substance by chemical or mechanical processes
An occlusion resulting in overstrain and injury to teeth, periodontal tissue, or other oral structures.
A masticatory muscle whose action is closing the jaws.
The wearing away of a tooth as a result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It is chiefly associated with aging. It is differentiated from TOOTH ABRASION (the pathologic wearing away of the tooth substance by friction, as brushing, bruxism, clenching, and other mechanical causes) and from TOOTH EROSION (the loss of substance caused by chemical action without bacterial action). (Jablonski, Dictionary of Dentistry, 1992, p86)
A symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors.
Increased salivary flow.
Protein synthesized by CLOSTRIDIUM TETANI as a single chain of ~150 kDa with 35% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS.
A painful linear ulcer at the margin of the anus. It appears as a crack or slit in the mucous membrane of the anus and is very painful and difficult to heal. (Dorland, 27th ed & Stedman, 25th ed)
A syndrome characterized by orofacial DYSTONIA; including BLEPHAROSPASM; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. It primarily affects older adults, with an incidence peak in the seventh decade of life. (From Adams et al., Principles of Neurology, 6th ed, p108)
Subtype of CLOSTRIDIUM BOTULINUM that produces BOTULINUM TOXINS, TYPE A which is neurotoxic to humans and animals.
Acquired or learned responses which are regularly manifested.
Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type E which is neurotoxic to humans and animals.
Muscles arising in the zygomatic arch that close the jaw. Their nerve supply is masseteric from the mandibular division of the trigeminal nerve. (From Stedman, 25th ed)
An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells, and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells.
Excessive sweating. In the localized type, the most frequent sites are the palms, soles, axillae, inguinal folds, and the perineal area. Its chief cause is thought to be emotional. Generalized hyperhidrosis may be induced by a hot, humid environment, by fever, or by vigorous exercise.
Introduction of substances into the body using a needle and syringe.
Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept.
An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
Recurrent clonic contraction of facial muscles, restricted to one side. It may occur as a manifestation of compressive lesions involving the seventh cranial nerve (FACIAL NERVE DISEASES), during recovery from BELL PALSY, or in association with other disorders. (From Adams et al., Principles of Neurology, 6th ed, p1378)
A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).
The mouth, teeth, jaws, pharynx, and related structures as they relate to mastication, deglutition, and speech.
The relationship of all the components of the masticatory system in normal function. It has special reference to the position and contact of the maxillary and mandibular teeth for the highest efficiency during the excursive movements of the jaw that are essential for mastication. (From Jablonski, Dictionary of Dentistry, 1992, p556, p472)
Muscles of facial expression or mimetic muscles that include the numerous muscles supplied by the facial nerve that are attached to and move the skin of the face. (From Stedman, 25th ed)
An artificial replacement for one or more natural teeth or part of a tooth, or associated structures, ranging from a portion of a tooth to a complete denture. The dental prosthesis is used for cosmetic or functional reasons, or both. DENTURES and specific types of dentures are also available. (From Boucher's Clinical Dental Terminology, 4th ed, p244 & Jablonski, Dictionary of Dentistry, 1992, p643)
Common form of habitual body manipulation which is an expression of tension.
Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
A potent mycotoxin produced in feedstuffs by several species of the genus FUSARIUM. It elicits a severe inflammatory reaction in animals and has teratogenic effects.
Rigid or flexible appliances that overlay the occlusal surfaces of the teeth. They are used to treat clenching and bruxism and their sequelae, and to provide temporary relief from muscle or temporomandibular joint pain.
Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)
A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
An autonomic disorder characterized by excessive sweating of the forehead, upper lip, perioral region, or sternum subsequent to gustatory stimuli. The auriculotemporal syndrome features facial flushing or sweating limited to the distribution of the auriculotemporal nerve and may develop after trauma to the parotid gland, in association with PAROTID NEOPLASMS, or following their surgical removal. (From Ann Neurol 1997 Dec;42(6):973-5)
A ubiquitous target SNARE protein that interacts with SYNTAXIN and SYNAPTOBREVIN. It is a core component of the machinery for intracellular MEMBRANE FUSION. The sequence contains 2 SNARE domains, one is the prototype for the Qb-SNARES, and the other is the prototype for the Qc-SNARES.
A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
The pathologic wearing away of the tooth substance by brushing, bruxism, clenching, and other mechanical causes. It is differentiated from TOOTH ATTRITION in that this type of wearing away is the result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It differs also from TOOTH EROSION, the progressive loss of the hard substance of a tooth by chemical processes not involving bacterial action. (From Jablonski, Dictionary of Dentistry, 1992, p2)
Perception of shape and form of objects by TOUCH, via tactile stimuli.
Abnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages.
Specific, characterizable, poisonous chemicals, often PROTEINS, with specific biological properties, including immunogenicity, produced by microbes, higher plants (PLANTS, TOXIC), or ANIMALS.
Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS.
The muscles that move the eye. Included in this group are the medial rectus, lateral rectus, superior rectus, inferior rectus, inferior oblique, superior oblique, musculus orbitalis, and levator palpebrae superioris.
Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
Plantar declination of the foot.
Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type B which is neurotoxic to humans and animals.
The act and process of chewing and grinding food in the mouth.
The phenomenon of youthfulness, vitality, and freshness being restored. This can apply to appearance, TISSUES, organ functions, or other areas.
The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight.
The teeth of the first dentition, which are shed and replaced by the permanent teeth.
Recording of the changes in electric potential of muscle by means of surface or needle electrodes.
Procedures for the improvement or enhancement of the appearance of the visible parts of the body.
Preparations of pathogenic organisms or their derivatives made nontoxic and intended for active immunologic prophylaxis. They include deactivated toxins. Anatoxin toxoids are distinct from anatoxins that are TROPANES found in CYANOBACTERIA.
Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type F which is neurotoxic to humans and animals.
The synapse between a neuron and a muscle.
An articulation between the condyle of the mandible and the articular tubercle of the temporal bone.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type D which is neurotoxic to ANIMALS, especially CATTLE, but not humans.
Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.
Injections introduced directly into localized lesions.
Toxic or poisonous substances elaborated by marine flora or fauna. They include also specific, characterized poisons or toxins for which there is no more specific heading, like those from poisonous FISHES.

Bruxism is the medical term for grinding or clenching your teeth. It's often an unconscious habit that can occur during the day or at night (nocturnal bruxism). Mild bruxism may not require treatment, but chronic, severe grinding can lead to jaw disorders, headaches, and damaged teeth.

There are several potential causes of bruxism, including stress, anxiety, certain medications, alcohol and drug use, and sleep disorders. Dentists often diagnose bruxism based on the visible signs of wear on your teeth, or they may ask you about symptoms you're experiencing. Treatment for bruxism can include stress management techniques, dental guards to protect your teeth during sleep, and in some cases, medication.

Sleep bruxism is a sleep-related movement disorder characterized by the involuntary clenching or grinding of teeth and jaw muscle activity during sleep, which can lead to tooth wear, jaw pain, headaches, and other oral health issues. It is typically considered a parasomnia, which is a type of abnormal behavior that occurs during sleep. The exact causes of sleep bruxism are not fully understood, but it may be associated with stress, certain medications, alcohol and drug use, and other factors. Treatment options can include stress management techniques, dental guards to protect the teeth, and in some cases, medication.

Botulinum toxins type A are neurotoxins produced by the bacterium Clostridium botulinum and related species. These toxins act by blocking the release of acetylcholine at the neuromuscular junction, leading to muscle paralysis. Botulinum toxin type A is used in medical treatments for various conditions characterized by muscle spasticity or excessive muscle activity, such as cervical dystonia, blepharospasm, strabismus, and chronic migraine. It is also used cosmetically to reduce the appearance of wrinkles by temporarily paralyzing the muscles that cause them. The commercial forms of botulinum toxin type A include Botox, Dysport, and Xeomin.

Botulinum toxins are neurotoxic proteins produced by the bacterium Clostridium botulinum and related species. They are the most potent naturally occurring toxins, and are responsible for the paralytic illness known as botulism. There are seven distinct botulinum toxin serotypes (A-G), each of which targets specific proteins in the nervous system, leading to inhibition of neurotransmitter release and subsequent muscle paralysis.

In clinical settings, botulinum toxins have been used for therapeutic purposes due to their ability to cause temporary muscle relaxation. Botulinum toxin type A (Botox) is the most commonly used serotype in medical treatments, including management of dystonias, spasticity, migraines, and certain neurological disorders. Additionally, botulinum toxins are widely employed in aesthetic medicine for reducing wrinkles and fine lines by temporarily paralyzing facial muscles.

It is important to note that while botulinum toxins have therapeutic benefits when used appropriately, they can also pose significant health risks if misused or improperly handled. Proper medical training and supervision are essential for safe and effective utilization of these powerful toxins.

Neuromuscular agents are drugs or substances that affect the function of the neuromuscular junction, which is the site where nerve impulses are transmitted to muscles. These agents can either enhance or inhibit the transmission of signals across the neuromuscular junction, leading to a variety of effects on muscle tone and activity.

Neuromuscular blocking agents (NMBAs) are a type of neuromuscular agent that is commonly used in anesthesia and critical care settings to induce paralysis during intubation or mechanical ventilation. NMBAs can be classified into two main categories: depolarizing and non-depolarizing agents.

Depolarizing NMBAs, such as succinylcholine, work by activating the nicotinic acetylcholine receptors at the neuromuscular junction, causing muscle contraction followed by paralysis. Non-depolarizing NMBAs, such as rocuronium and vecuronium, block the activation of these receptors, preventing muscle contraction and leading to paralysis.

Other types of neuromuscular agents include cholinesterase inhibitors, which increase the levels of acetylcholine at the neuromuscular junction and can be used to reverse the effects of NMBAs, and botulinum toxin, which is a potent neurotoxin that inhibits the release of acetylcholine from nerve terminals and is used in the treatment of various neurological disorders.

'Clostridium botulinum' is a gram-positive, rod-shaped, anaerobic bacteria that produces one or more neurotoxins known as botulinum toxins. These toxins are among the most potent naturally occurring biological poisons and can cause a severe form of food poisoning called botulism in humans and animals. Botulism is characterized by symmetrical descending flaccid paralysis, which can lead to respiratory and cardiovascular failure, and ultimately death if not treated promptly.

The bacteria are widely distributed in nature, particularly in soil, sediments, and the intestinal tracts of some animals. They can form spores that are highly resistant to heat, chemicals, and other environmental stresses, allowing them to survive for long periods in adverse conditions. The spores can germinate and produce vegetative cells and toxins when they encounter favorable conditions, such as anaerobic environments with appropriate nutrients.

Human botulism can occur through three main routes of exposure: foodborne, wound, and infant botulism. Foodborne botulism results from consuming contaminated food containing preformed toxins, while wound botulism occurs when the bacteria infect a wound and produce toxins in situ. Infant botulism is caused by the ingestion of spores that colonize the intestines and produce toxins, mainly affecting infants under one year of age.

Prevention measures include proper food handling, storage, and preparation practices, such as cooking and canning foods at appropriate temperatures and for sufficient durations. Wound care and prompt medical attention are crucial in preventing wound botulism. Vaccines and antitoxins are available for prophylaxis and treatment of botulism in high-risk individuals or in cases of confirmed exposure.

Anti-dyskinetic agents are a class of medications that are used to treat or manage dyskinesias, which are involuntary movements or abnormal muscle contractions. These medications work by blocking or reducing the activity of dopamine, a neurotransmitter in the brain that is involved in movement control.

Dyskinetic symptoms can occur as a side effect of long-term use of levodopa therapy in patients with Parkinson's disease. Anti-dyskinetic agents such as amantadine, anticholinergics, and dopamine agonists may be used to manage these symptoms.

Amantadine works by increasing the release of dopamine and blocking its reuptake, which can help reduce dyskinesias. Anticholinergic medications such as trihexyphenidyl and benztropine work by blocking the action of acetylcholine, another neurotransmitter that can contribute to dyskinesias. Dopamine agonists such as pramipexole and ropinirole mimic the effects of dopamine in the brain and can help reduce dyskinesias by reducing the dose of levodopa required for symptom control.

It is important to note that anti-dyskinetic agents may have side effects, and their use should be carefully monitored by a healthcare provider.

Botulism is a rare but serious condition caused by the toxin produced by the bacterium Clostridium botulinum. The neurotoxin causes muscle paralysis, which can lead to respiratory failure and death if not treated promptly. Botulism can occur in three main forms: foodborne, wound, and infant.

Foodborne botulism is caused by consuming contaminated food, usually home-canned or fermented foods with low acid content. Wound botulism occurs when the bacterium infects a wound and produces toxin in the body. Infant botulism affects babies under one year of age who have ingested spores of the bacterium, which then colonize the intestines and produce toxin.

Symptoms of botulism include double vision, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, muscle weakness, and paralysis that progresses downward from the head to the limbs. Treatment typically involves supportive care such as mechanical ventilation, intensive care unit monitoring, and antitoxin therapy. Prevention measures include proper food handling and canning techniques, prompt wound care, and avoiding consumption of known sources of contaminated food.

Botulinum antitoxin refers to a medication made from the antibodies that are generated in response to the botulinum toxin, which is produced by the bacterium Clostridium botulinum. Botulinum toxin is a potent neurotoxin that can cause paralysis and other serious medical complications in humans and animals.

The antitoxin works by neutralizing the effects of the toxin in the body, preventing further damage to the nervous system. It is typically used in emergency situations to treat individuals who have been exposed to large amounts of botulinum toxin, such as in a bioterrorism attack or accidental exposure in a laboratory setting.

Botulinum antitoxin is not the same as botulinum toxin type A (Botox), which is a purified form of the toxin that is used for cosmetic and therapeutic purposes. Botox works by temporarily paralyzing muscles, whereas the antitoxin works by neutralizing the toxin in the body.

Blepharospasm is a medical condition characterized by involuntary spasms and contractions of the muscles around the eyelids. These spasms can cause frequent blinkings, eye closure, and even difficulty in keeping the eyes open. In some cases, the spasms may be severe enough to interfere with vision, daily activities, and quality of life.

The exact cause of blepharospasm is not fully understood, but it is believed to involve abnormal functioning of the basal ganglia, a part of the brain that controls movement. It can occur as an isolated condition (known as essential blepharospasm) or as a symptom of other neurological disorders such as Parkinson's disease or dystonia.

Treatment options for blepharospasm may include medication, botulinum toxin injections, surgery, or a combination of these approaches. The goal of treatment is to reduce the frequency and severity of the spasms, improve symptoms, and enhance the patient's quality of life.

A spasm is a sudden, involuntary contraction or tightening of a muscle, group of muscles, or a hollow organ such as the ureter or bronchi. Spasms can occur as a result of various factors including muscle fatigue, injury, irritation, or abnormal nerve activity. They can cause pain and discomfort, and in some cases, interfere with normal bodily functions. For example, a spasm in the bronchi can cause difficulty breathing, while a spasm in the ureter can cause severe pain and may lead to a kidney stone blockage. The treatment for spasms depends on the underlying cause and may include medication, physical therapy, or lifestyle changes.

Muscle spasticity is a motor disorder characterized by an involuntary increase in muscle tone, leading to stiffness and difficulty in moving muscles. It is often seen in people with damage to the brain or spinal cord, such as those with cerebral palsy, multiple sclerosis, or spinal cord injuries.

In muscle spasticity, the muscles may contract excessively, causing rigid limbs, awkward movements, and abnormal postures. The severity of muscle spasticity can vary from mild stiffness to severe contractures that limit mobility and function.

Muscle spasticity is caused by an imbalance between excitatory and inhibitory signals in the central nervous system, leading to overactivity of the alpha motor neurons that control muscle contraction. This can result in hyperreflexia (overactive reflexes), clonus (rapid, rhythmic muscle contractions), and flexor or extensor spasms.

Effective management of muscle spasticity may involve a combination of physical therapy, medication, surgery, or other interventions to improve function, reduce pain, and prevent complications such as contractures and pressure sores.

"Intramuscular injections" refer to a medical procedure where a medication or vaccine is administered directly into the muscle tissue. This is typically done using a hypodermic needle and syringe, and the injection is usually given into one of the large muscles in the body, such as the deltoid (shoulder), vastus lateralis (thigh), or ventrogluteal (buttock) muscles.

Intramuscular injections are used for a variety of reasons, including to deliver medications that need to be absorbed slowly over time, to bypass stomach acid and improve absorption, or to ensure that the medication reaches the bloodstream quickly and directly. Common examples of medications delivered via intramuscular injection include certain vaccines, antibiotics, and pain relievers.

It is important to follow proper technique when administering intramuscular injections to minimize pain and reduce the risk of complications such as infection or injury to surrounding tissues. Proper site selection, needle length and gauge, and injection technique are all critical factors in ensuring a safe and effective intramuscular injection.

Torticollis, also known as wry neck, is a condition where the neck muscles contract and cause the head to turn to one side. There are different types of torticollis including congenital (present at birth), acquired (develops after birth), and spasmodic (neurological).

Congenital torticollis can be caused by a tight or shortened sternocleidomastoid muscle in the neck, which can occur due to positioning in the womb or abnormal blood vessels in the muscle. Acquired torticollis can result from injury, infection, or tumors in the neck. Spasmodic torticollis is a neurological disorder that causes involuntary contractions of the neck muscles and can be caused by a variety of factors including genetics, environmental toxins, or head trauma.

Symptoms of torticollis may include difficulty turning the head, tilting the chin upwards or downwards, pain or discomfort in the neck, and a limited range of motion. Treatment for torticollis depends on the underlying cause and can include physical therapy, stretching exercises, medication, or surgery.

Tooth wear is the progressive loss of tooth structure that can occur as a result of various factors. According to the medical definition, it refers to the wearing down, rubbing away, or grinding off of the hard tissues of the teeth (enamel and dentin) due to mechanical forces or chemical processes.

There are three primary types of tooth wear:

1. Abrasion: This is the loss of tooth structure caused by friction from external sources, such as incorrect brushing techniques, bite appliances, or habits like nail-biting and pipe smoking.
2. Attrition: This type of tooth wear results from the natural wearing down of teeth due to occlusal forces during biting, chewing, and grinding. However, excessive attrition can occur due to bruxism (teeth grinding) or clenching.
3. Erosion: Chemical processes, such as acid attacks from dietary sources (e.g., citrus fruits, sodas, and sports drinks) or gastric reflux, cause the loss of tooth structure in this type of tooth wear. The enamel dissolves when exposed to low pH levels, leaving the dentin underneath vulnerable to further damage.

Professional dental examination and treatment may be necessary to address significant tooth wear and prevent further progression, which can lead to sensitivity, pain, and functional or aesthetic issues.

Dental occlusion, traumatic is a term used to describe an abnormal bite or contact between the upper and lower teeth that results in trauma or injury to the oral structures. This can occur when there is a discrepancy in the alignment of the teeth or jaws, such as an overbite, underbite, or crossbite, which causes excessive force or pressure on certain teeth or tissues.

Traumatic dental occlusion can result in various dental and oral health issues, including tooth wear, fractures, mobility of teeth, gum recession, and temporomandibular joint (TMJ) disorders. It is important to diagnose and treat traumatic dental occlusion early to prevent further damage and alleviate any discomfort or pain. Treatment options may include orthodontic treatment, adjustment of the bite, restoration of damaged teeth, or a combination of these approaches.

The masseter muscle is a strong chewing muscle in the jaw. It is a broad, thick, quadrilateral muscle that extends from the zygomatic arch (cheekbone) to the lower jaw (mandible). The masseter muscle has two distinct parts: the superficial part and the deep part.

The superficial part of the masseter muscle originates from the lower border of the zygomatic process of the maxilla and the anterior two-thirds of the inferior border of the zygomatic arch. The fibers of this part run almost vertically downward to insert on the lateral surface of the ramus of the mandible and the coronoid process.

The deep part of the masseter muscle originates from the deep surface of the zygomatic arch and inserts on the medial surface of the ramus of the mandible, blending with the temporalis tendon.

The primary function of the masseter muscle is to elevate the mandible, helping to close the mouth and clench the teeth together during mastication (chewing). It also plays a role in stabilizing the jaw during biting and speaking. The masseter muscle is one of the most powerful muscles in the human body relative to its size.

Tooth attrition is a type of wear on the teeth that results from normal dental occlusal forces during biting, chewing, and grinding of food. It involves the loss of tooth structure by mechanical forces and is typically seen as a flattening or reduction in the vertical height of the crowns of teeth.

Attrition differs from other types of tooth wear such as abrasion (which is caused by external factors like toothbrush bristles, toothpaste, or habitual pen/pencil biting), erosion (which is caused by chemical dissolution of tooth structure due to acid exposure), and abfraction (which is caused by flexural forces leading to cervical lesions).

While some degree of attrition is considered a normal part of the aging process, excessive attrition can lead to dental sensitivity, aesthetic concerns, and even affect the functionality of the teeth and overall oral health. Dental professionals may recommend various treatments such as fillings, crowns, or even orthodontic interventions to manage the consequences of severe tooth attrition.

Temporomandibular Joint Dysfunction Syndrome, often abbreviated as TMJD or TMD, is a group of conditions that cause pain and dysfunction in the temporomandibular joint (TMJ) - the joint that connects the jawbone to the skull. Here's a more detailed medical definition:

Temporomandibular Joint Dysfunction Syndrome is a complex disorder characterized by pain, clicking, popping, or grating sounds in the TMJ; limited movement or locking of the jaw; and/or painful chewing movements. The condition may be caused by a variety of factors, including muscle tension, joint inflammation, structural problems with the joint itself, or injury to the head, neck, or jaw.

Symptoms of TMJD can include:
- Pain or tenderness in the face, jaw joint area, neck, and/or shoulders
- Limited ability to open the mouth wide
- Jaw locking, making it difficult to close or open the mouth
- Clicking, popping, or grating sounds in the TMJ when opening or closing the mouth
- A significant change in the way the upper and lower teeth fit together
- Headaches, earaches, dizziness, and hearing problems

Treatment for TMJD can vary depending on the severity of the condition and its underlying cause. It may include self-care practices such as eating soft foods, avoiding extreme jaw movements, and practicing relaxation techniques; physical therapy; medication to reduce pain and inflammation; dental treatments such as mouthguards or bite adjustments; and, in rare cases, surgery.

Sialorrhea is the medical term for excessive drooling or saliva production. It's not necessarily a condition where the person produces too much saliva, but rather, they are unable to control the normal amount of saliva in their mouth due to various reasons such as neurological disorders, developmental disabilities, or structural issues that affect swallowing and oral motor function.

Common causes include cerebral palsy, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Down syndrome, stroke, intellectual disability, and certain medications. Treatment options vary depending on the cause and severity of the condition and may include medication adjustments, behavioral interventions, oral devices, or even surgical procedures in severe cases.

Tetanus toxin, also known as tetanospasmin, is a potent neurotoxin produced by the bacterium Clostridium tetani. This toxin binds to nerve endings and is transported to the nervous system's inhibitory neurons, where it blocks the release of inhibitory neurotransmitters, particularly glycine and GABA (gamma-aminobutyric acid). As a result, it causes uncontrolled muscle contractions or spasms, which are the hallmark symptoms of tetanus disease.

The toxin has two main components: an N-terminal portion called the light chain, which is the enzymatically active part that inhibits neurotransmitter release, and a C-terminal portion called the heavy chain, which facilitates the toxin's entry into neurons. The heavy chain also contains a binding domain that allows the toxin to recognize specific receptors on nerve cells.

Tetanus toxin is one of the most potent toxins known, with an estimated human lethal dose of just 2.5-3 nanograms per kilogram of body weight when introduced into the bloodstream. Fortunately, tetanus can be prevented through vaccination with the tetanus toxoid, which is part of the standard diphtheria-tetanus-pertussis (DTaP or Tdap) immunization series for children and adolescents and the tetanus-diphtheria (Td) booster for adults.

A fissure in ano, also known as anal fissure, is a linear tear or split in the lining of the anus, usually occurring in the posterior midline. It can cause pain and bleeding during bowel movements. Anal fissures are often caused by constipation, passing hard stools, or prolonged diarrhea. They can also be associated with underlying conditions such as inflammatory bowel disease or anal cancer. Treatment typically involves increasing fiber intake, using stool softeners, and topical treatments to promote healing and relieve pain. In some cases, surgery may be required for severe or chronic fissures that do not respond to conservative treatment.

Meige Syndrome, also known as Brueghel's syndrome or Hemifacial spasm-blepharospasm syndrome, is a rare neurological disorder characterized by the simultaneous contraction of muscles in the face, neck, and sometimes other parts of the body. It is a form of dystonia, which is a movement disorder that causes involuntary muscle contractions and abnormal postures.

Meige Syndrome is typically divided into two types:

1. Ocular Meige Syndrome: This type primarily affects the muscles around the eyes, causing involuntary spasms, blinks, and eyelid closure.
2. Cranio-cervical Dystonia or Brueghel's syndrome: This type involves both the cranial (head) and cervical (neck) regions, leading to abnormal head postures, neck pain, and involuntary movements of the facial muscles.

The exact cause of Meige Syndrome is not fully understood, but it is believed to be related to abnormal functioning in the basal ganglia, a part of the brain responsible for controlling movement. In some cases, it may be associated with structural lesions or vascular abnormalities in the brain.

Treatment options for Meige Syndrome include medications such as botulinum toxin (Botox) injections, which help to relax the overactive muscles and reduce spasms. In severe cases, surgical interventions may be considered.

'Clostridium botulinum type A' is a gram-positive, anaerobic, spore-forming bacterium that produces a potent neurotoxin known as botulinum toxin type A. This toxin is one of the most deadly substances known, with a lethal dose estimated to be as low as 1 nanogram per kilogram of body weight. The bacterium and its toxin are the causative agents of botulism, a rare but serious paralytic illness in humans and animals.

The neurotoxin produced by Clostridium botulinum type A works by blocking the release of acetylcholine, a neurotransmitter that is essential for muscle contraction. This results in flaccid paralysis, which can affect the muscles used for breathing and lead to respiratory failure and death if not treated promptly.

Botulinum toxin type A has also found therapeutic use in the treatment of various medical conditions, including strabismus, blepharospasm, cervical dystonia, and chronic migraine. It is marketed under the brand names Botox, Dysport, and Xeomin, among others. However, it is important to note that these therapeutic uses involve carefully controlled doses administered by trained medical professionals, and should not be attempted outside of a clinical setting.

In the context of medical terminology, a "habit" refers to a regular, repeated behavior or practice that is often performed automatically or subconsciously. Habits can be physical (such as biting nails) or mental (such as worrying). They can be harmless, beneficial (like regularly brushing your teeth), or harmful (like smoking cigarettes).

Habits are different from instincts or reflexes because they involve a learned behavior that has been repeated and reinforced over time. Breaking a habit can often be challenging due to the deeply ingrained nature of the behavior.

'Clostridium botulinum type E' is a gram-positive, spore-forming anaerobic bacterium that produces the neurotoxin botulinum toxin type E. This toxin is one of the seven types of botulinum neurotoxins (A-G) produced by various strains of Clostridium botulinum and related species. The botulinum toxin type E causes a form of botulism, a rare but serious illness characterized by muscle paralysis that can lead to respiratory failure and death.

Botulism caused by C. botulinum type E is often associated with the consumption of contaminated fish or marine products in aquatic environments of cold temperature, such as the Baltic and North Seas, and the Great Lakes in North America. The spores of this bacterium are resistant to heat and can survive in improperly processed or preserved food, leading to intoxication when ingested.

Preventive measures include proper handling, storage, and cooking of susceptible foods, as well as prompt medical attention if symptoms of botulism appear, such as double vision, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, and muscle weakness. Botulinum toxin type E antitoxin is available for the treatment of botulism caused by this strain, but early diagnosis and intervention are crucial for a favorable prognosis.

Masticatory muscles are a group of skeletal muscles responsible for the mastication (chewing) process in humans and other animals. They include:

1. Masseter muscle: This is the primary muscle for chewing and is located on the sides of the face, running from the lower jawbone (mandible) to the cheekbone (zygomatic arch). It helps close the mouth and elevate the mandible during chewing.

2. Temporalis muscle: This muscle is situated in the temporal region of the skull, covering the temple area. It assists in closing the jaw, retracting the mandible, and moving it sideways during chewing.

3. Medial pterygoid muscle: Located deep within the cheek, near the angle of the lower jaw, this muscle helps move the mandible forward and grind food during chewing. It also contributes to closing the mouth.

4. Lateral pterygoid muscle: Found inside the ramus (the vertical part) of the mandible, this muscle has two heads - superior and inferior. The superior head helps open the mouth by pulling the temporomandibular joint (TMJ) downwards, while the inferior head assists in moving the mandible sideways during chewing.

These muscles work together to enable efficient chewing and food breakdown, preparing it for swallowing and digestion.

Cholera toxin is a protein toxin produced by the bacterium Vibrio cholerae, which causes the infectious disease cholera. The toxin is composed of two subunits, A and B, and its primary mechanism of action is to alter the normal function of cells in the small intestine.

The B subunit of the toxin binds to ganglioside receptors on the surface of intestinal epithelial cells, allowing the A subunit to enter the cell. Once inside, the A subunit activates a signaling pathway that results in the excessive secretion of chloride ions and water into the intestinal lumen, leading to profuse, watery diarrhea, dehydration, and other symptoms associated with cholera.

Cholera toxin is also used as a research tool in molecular biology and immunology due to its ability to modulate cell signaling pathways. It has been used to study the mechanisms of signal transduction, protein trafficking, and immune responses.

Hyperhidrosis is a medical condition characterized by excessive sweating beyond the normal requirement for thermoregulation. It can affect various parts of the body, but it primarily occurs in the palms, soles, underarms, and face. The sweating can be so profuse that it can interfere with daily activities and cause significant distress or embarrassment. Hyperhidrosis can be primary (idiopathic), meaning there is no underlying medical condition causing it, or secondary, due to a known cause such as anxiety, certain medications, infections, or medical conditions like diabetes or hyperthyroidism.

An injection is a medical procedure in which a medication, vaccine, or other substance is introduced into the body using a needle and syringe. The substance can be delivered into various parts of the body, including into a vein (intravenous), muscle (intramuscular), under the skin (subcutaneous), or into the spinal canal (intrathecal or spinal).

Injections are commonly used to administer medications that cannot be taken orally, have poor oral bioavailability, need to reach the site of action quickly, or require direct delivery to a specific organ or tissue. They can also be used for diagnostic purposes, such as drawing blood samples (venipuncture) or injecting contrast agents for imaging studies.

Proper technique and sterile conditions are essential when administering injections to prevent infection, pain, and other complications. The choice of injection site depends on the type and volume of the substance being administered, as well as the patient's age, health status, and personal preferences.

Neurotoxins are substances that are poisonous or destructive to nerve cells (neurons) and the nervous system. They can cause damage by destroying neurons, disrupting communication between neurons, or interfering with the normal functioning of the nervous system. Neurotoxins can be produced naturally by certain organisms, such as bacteria, plants, and animals, or they can be synthetic compounds created in a laboratory. Examples of neurotoxins include botulinum toxin (found in botulism), tetrodotoxin (found in pufferfish), and heavy metals like lead and mercury. Neurotoxic effects can range from mild symptoms such as headaches, muscle weakness, and tremors, to more severe symptoms such as paralysis, seizures, and cognitive impairment. Long-term exposure to neurotoxins can lead to chronic neurological conditions and other health problems.

Dystonia is a neurological movement disorder characterized by involuntary muscle contractions, leading to repetitive or twisting movements. These movements can be painful and may affect one part of the body (focal dystonia) or multiple parts (generalized dystonia). The exact cause of dystonia varies, with some cases being inherited and others resulting from damage to the brain. Treatment options include medications, botulinum toxin injections, and deep brain stimulation surgery.

Hemifacial spasm is a neuromuscular disorder characterized by involuntary, irregular contractions or twitching of the muscles on one side of the face. These spasms typically begin around the eye and may progress to involve the muscles of the lower face, including those around the mouth.

The primary cause of hemifacial spasm is pressure on or irritation of the facial nerve (cranial nerve VII) as it exits the brainstem, often due to a blood vessel or tumor. This pressure can lead to abnormal electrical signals in the facial nerve, resulting in uncontrolled muscle contractions.

In some cases, hemifacial spasm may be associated with other conditions such as multiple sclerosis or Bell's palsy. Treatment options for hemifacial spasm include medications to help relax the muscles, botulinum toxin (Botox) injections to paralyze the affected muscles temporarily, and, in rare cases, surgical intervention to relieve pressure on the facial nerve.

Esophageal achalasia is a rare disorder of the esophagus, the tube that carries food from the mouth to the stomach. In this condition, the muscles at the lower end of the esophagus fail to relax properly during swallowing, making it difficult for food and liquids to pass into the stomach. This results in symptoms such as difficulty swallowing (dysphagia), regurgitation of food, chest pain, and weight loss. The cause of esophageal achalasia is not fully understood, but it is believed to be related to damage to the nerves that control the muscles of the esophagus. Treatment options include medications to relax the lower esophageal sphincter, botulinum toxin injections, and surgical procedures such as laparoscopic Heller myotomy or peroral endoscopic myotomy (POEM).

The stomatognathic system is a term used in medicine and dentistry to refer to the coordinated functions of the mouth, jaw, and related structures. It includes the teeth, gums, tongue, palate, lips, cheeks, salivary glands, as well as the muscles of mastication (chewing), swallowing, and speech. The stomatognathic system also involves the temporomandibular joint (TMJ) and associated structures that allow for movement of the jaw. This complex system works together to enable functions such as eating, speaking, and breathing. Dysfunction in the stomatognathic system can lead to various oral health issues, including temporomandibular disorders, occlusal problems, and orofacial pain.

Dental occlusion refers to the alignment and contact between the upper and lower teeth when the jaws are closed. It is the relationship between the maxillary (upper) and mandibular (lower) teeth when they approach each other, as occurs during chewing or biting.

A proper dental occlusion, also known as a balanced occlusion, ensures that the teeth and jaw joints function harmoniously, reducing the risk of tooth wear, damage, and temporomandibular disorders (TMD). Malocclusion, on the other hand, refers to improper alignment or contact between the upper and lower teeth, which may require orthodontic treatment or dental restorations to correct.

Facial muscles, also known as facial nerves or cranial nerve VII, are a group of muscles responsible for various expressions and movements of the face. These muscles include:

1. Orbicularis oculi: muscle that closes the eyelid and raises the upper eyelid
2. Corrugator supercilii: muscle that pulls the eyebrows down and inward, forming wrinkles on the forehead
3. Frontalis: muscle that raises the eyebrows and forms horizontal wrinkles on the forehead
4. Procerus: muscle that pulls the medial ends of the eyebrows downward, forming vertical wrinkles between the eyebrows
5. Nasalis: muscle that compresses or dilates the nostrils
6. Depressor septi: muscle that pulls down the tip of the nose
7. Levator labii superioris alaeque nasi: muscle that raises the upper lip and flares the nostrils
8. Levator labii superioris: muscle that raises the upper lip
9. Zygomaticus major: muscle that raises the corner of the mouth, producing a smile
10. Zygomaticus minor: muscle that raises the nasolabial fold and corner of the mouth
11. Risorius: muscle that pulls the angle of the mouth laterally, producing a smile
12. Depressor anguli oris: muscle that pulls down the angle of the mouth
13. Mentalis: muscle that raises the lower lip and forms wrinkles on the chin
14. Buccinator: muscle that retracts the cheek and helps with chewing
15. Platysma: muscle that depresses the corner of the mouth and wrinkles the skin of the neck.

These muscles are innervated by the facial nerve, which arises from the brainstem and exits the skull through the stylomastoid foramen. Damage to the facial nerve can result in facial paralysis or weakness on one or both sides of the face.

A dental prosthesis is a device that replaces one or more missing teeth or parts of teeth to correct deficiencies in chewing ability, speech, and aesthetics. It can be removable or fixed (permanent) and can be made from various materials such as acrylic resin, porcelain, metal alloys, or a combination of these. Examples of dental prostheses include dentures, bridges, crowns, and implants.

The medical term for nail biting is "Onychophagia." It's classified as a type of body-focused repetitive behavior, which is a category of mental health disorders characterized by the repeated compulsion to engage in certain self-grooming behaviors that cause physical damage. In the case of onychophagia, the individual repeatedly bites their nails, often until they bleed or become severely damaged. This can lead to various complications, such as infection and dental issues. It's important to note that while nail biting is a common habit, when it becomes repetitive, compulsive, and causes significant distress or impairment, it may be indicative of a broader mental health condition.

Dystonic disorders are a group of neurological conditions characterized by sustained or intermittent muscle contractions that result in involuntary, repetitive, and often twisting movements and abnormal postures. These movements can affect any part of the body, including the face, neck, limbs, and trunk. Dystonic disorders can be primary, meaning they are caused by genetic mutations or idiopathic causes, or secondary, resulting from brain injury, infection, or other underlying medical conditions.

The most common form of dystonia is cervical dystonia (spasmodic torticollis), which affects the muscles of the neck and results in abnormal head positioning. Other forms of dystonia include blepharospasm (involuntary eyelid spasms), oromandibular dystonia (affecting the muscles of the jaw, face, and tongue), and generalized dystonia (affecting multiple parts of the body).

Dystonic disorders can significantly impact a person's quality of life, causing pain, discomfort, and social isolation. Treatment options include oral medications, botulinum toxin injections, and deep brain stimulation surgery in severe cases.

T-2 toxin is a type B trichothecene mycotoxin, which is a secondary metabolite produced by certain Fusarium species of fungi. It is a low molecular weight sesquiterpene epoxide that is chemically stable and has a high toxicity profile. T-2 toxin can contaminate crops in the field or during storage, and it is often found in grains such as corn, wheat, barley, and oats.

T-2 toxin has a variety of adverse health effects, including nausea, vomiting, diarrhea, abdominal pain, immune suppression, skin irritation, and neurotoxicity. It is also known to have teratogenic and embryotoxic effects in animals, and it is considered a potential human carcinogen by some agencies.

Exposure to T-2 toxin can occur through ingestion, inhalation, or skin contact. Ingestion is the most common route of exposure, particularly in areas where contaminated grains are used as a food source. Inhalation exposure can occur during agricultural activities such as harvesting and processing contaminated crops. Skin contact with T-2 toxin can cause irritation and inflammation.

Prevention of T-2 toxin exposure involves good agricultural practices, including crop rotation, use of resistant varieties, and proper storage conditions. Monitoring of T-2 toxin levels in food and feed is also important to ensure that exposure limits are not exceeded.

Occlusal splints, also known as bite guards or night guards, are removable dental appliances that are used to provide protection and stabilization for the teeth and jaw joint (temporomandibular joint or TMJ). They are typically made of hard acrylic or soft materials and are custom-fit to a patient's mouth.

Occlusal splints work by covering and separating the upper and lower teeth, preventing them from coming into contact with each other. This can help to reduce tooth grinding and clenching (bruxism), which can cause tooth wear, sensitivity, and TMJ disorders. They may also be used to help stabilize the jaw joint and muscles in patients with TMJ disorders or to provide protection for teeth that have undergone restorative dental work.

It is important to note that occlusal splints should only be worn under the guidance of a dentist, as improper use can lead to further dental problems.

Facial pain is a condition characterized by discomfort or pain felt in any part of the face. It can result from various causes, including nerve damage or irritation, injuries, infections, dental problems, migraines, or sinus congestion. The pain can range from mild to severe and may be sharp, dull, constant, or intermittent. In some cases, facial pain can also be associated with other symptoms such as headaches, redness, swelling, or changes in sensation. Accurate diagnosis and treatment of the underlying cause are essential for effective management of facial pain.

Temporomandibular Joint Disorders (TMD) refer to a group of conditions that cause pain and dysfunction in the temporomandibular joint (TMJ) and the muscles that control jaw movement. The TMJ is the hinge joint that connects the lower jaw (mandible) to the skull (temporal bone) in front of the ear. It allows for movements required for activities such as eating, speaking, and yawning.

TMD can result from various causes, including:

1. Muscle tension or spasm due to clenching or grinding teeth (bruxism), stress, or jaw misalignment
2. Dislocation or injury of the TMJ disc, which is a small piece of cartilage that acts as a cushion between the bones in the joint
3. Arthritis or other degenerative conditions affecting the TMJ
4. Bite problems (malocclusion) leading to abnormal stress on the TMJ and its surrounding muscles
5. Stress, which can exacerbate existing TMD symptoms by causing muscle tension

Symptoms of Temporomandibular Joint Disorders may include:
- Pain or tenderness in the jaw, face, neck, or shoulders
- Limited jaw movement or locking of the jaw
- Clicking, popping, or grating sounds when moving the jaw
- Headaches, earaches, or dizziness
- Difficulty chewing or biting
- Swelling on the side of the face

Treatment for TMD varies depending on the severity and cause of the condition. It may include self-care measures (like eating soft foods, avoiding extreme jaw movements, and applying heat or cold packs), physical therapy, medications (such as muscle relaxants, pain relievers, or anti-inflammatory drugs), dental work (including bite adjustments or orthodontic treatment), or even surgery in severe cases.

Hydroxyzine is an antihistamine medication that is primarily used to treat symptoms of allergies such as itching, hives, and swelling. It works by blocking the effects of histamine, a substance in the body that causes allergic reactions. In addition to its antihistaminic properties, hydroxyzine also has sedative and anxiety-reducing effects, which make it useful in treating anxiety disorders, symptoms of alcohol withdrawal, and as a sleep aid. It is available in both oral and injectable forms and is usually taken orally in the form of tablets, capsules, or syrup. As with any medication, hydroxyzine should be used under the supervision of a healthcare provider, and its use may be subject to certain precautions and contraindications depending on the individual's medical history and current health status.

Gustatory sweating, also known as Frey's syndrome, is a condition in which an individual experiences excessive sweating on the face, neck, and scalp while eating, especially spicy or strong-flavored foods. This unusual form of sweating occurs due to an abnormal cross-innervation between the sympathetic and parasympathetic nerves that supply the salivary glands and sweat glands in the skin of the face and neck.

Normally, when we eat, our body activates the parasympathetic nervous system to stimulate saliva production for digestion. In some individuals, this activation can cause an aberrant response where sympathetic nerve fibers are also activated, leading to sweating in the affected areas. This condition is often a result of damage or injury to the nerves in the face, such as after surgery (particularly facial nerve or parotid gland surgeries), trauma, or infection.

Synaptosomal-associated protein 25 (SNAP-25) is a protein found in the presynaptic membrane of neurons, which plays a crucial role in the process of synaptic transmission. It is a component of the SNARE complex, a group of proteins that facilitate vesicle docking and fusion with the presynaptic membrane during neurotransmitter release. SNAP-25 binds to other SNARE proteins, syntaxin and VAMP (vesicle-associated membrane protein), forming a tight complex that brings the vesicle membrane into close apposition with the presynaptic membrane, allowing for the fusion of the two membranes and the release of neurotransmitters into the synaptic cleft.

Cerebral palsy (CP) is a group of disorders that affect a person's ability to move and maintain balance and posture. According to the Mayo Clinic, CP is caused by abnormal brain development or damage to the developing brain that affects a child's ability to control movement.

The symptoms of cerebral palsy can vary in severity and may include:

* Spasticity (stiff or tight muscles)
* Rigidity (resistance to passive movement)
* Poor coordination and balance
* Weakness or paralysis
* Tremors or involuntary movements
* Abnormal gait or difficulty walking
* Difficulty with fine motor skills, such as writing or using utensils
* Speech and language difficulties
* Vision, hearing, or swallowing problems

It's important to note that cerebral palsy is not a progressive condition, meaning that it does not worsen over time. However, the symptoms may change over time, and some individuals with CP may experience additional medical conditions as they age.

Cerebral palsy is usually caused by brain damage that occurs before or during birth, but it can also be caused by brain injuries that occur in the first few years of life. Some possible causes of cerebral palsy include:

* Infections during pregnancy
* Lack of oxygen to the brain during delivery
* Traumatic head injury during birth
* Brain bleeding or stroke in the newborn period
* Genetic disorders
* Maternal illness or infection during pregnancy

There is no cure for cerebral palsy, but early intervention and treatment can help improve outcomes and quality of life. Treatment may include physical therapy, occupational therapy, speech therapy, medications to manage symptoms, surgery, and assistive devices such as braces or wheelchairs.

Tooth abrasion is defined as the wearing away of tooth structure due to mechanical forces from activities such as tooth brushing, chewing, or habits like nail biting or pen chewing. It typically occurs at the gum line and can result in sensitive teeth, notches in the teeth near the gums, and even tooth loss if left untreated. The use of hard-bristled toothbrushes, excessive force while brushing, and abrasive toothpastes can all contribute to tooth abrasion.

Stereognosis is a medical term that refers to the ability to identify and recognize the form, size, and texture of an object by using tactile (touch) sensation without visual or auditory input. It's a component of sensory perception that allows us to understand the three-dimensional shape and nature of objects through touch alone.

Loss or impairment of stereognosis can be a sign of neurological disorders, such as damage to the sensory cortex in the parietal lobe of the brain. Testing stereognosis is often part of a neurological examination to assess the functioning of the nervous system and the sense of touch.

Mouth breathing is a condition characterized by the regular habit of breathing through the mouth instead of the nose during awake states and sometimes during sleep. This can occur due to various reasons such as nasal congestion, deviated septum, enlarged tonsils or adenoids, or structural abnormalities in the jaw or airway. Prolonged mouth breathing can lead to several oral and general health issues, including dry mouth, bad breath, gum disease, and orthodontic problems. It can also affect sleep quality and cognitive function.

Biological toxins are poisonous substances that are produced by living organisms such as bacteria, plants, and animals. They can cause harm to humans, animals, or the environment. Biological toxins can be classified into different categories based on their mode of action, such as neurotoxins (affecting the nervous system), cytotoxins (damaging cells), and enterotoxins (causing intestinal damage).

Examples of biological toxins include botulinum toxin produced by Clostridium botulinum bacteria, tetanus toxin produced by Clostridium tetani bacteria, ricin toxin from the castor bean plant, and saxitoxin produced by certain types of marine algae.

Biological toxins can cause a range of symptoms depending on the type and amount of toxin ingested or exposed to, as well as the route of exposure (e.g., inhalation, ingestion, skin contact). They can cause illnesses ranging from mild to severe, and some can be fatal if not treated promptly and effectively.

Prevention and control measures for biological toxins include good hygiene practices, vaccination against certain toxin-producing bacteria, avoidance of contaminated food or water sources, and personal protective equipment (PPE) when handling or working with potential sources of toxins.

Antitoxins are substances, typically antibodies, that neutralize toxins produced by bacteria or other harmful organisms. They work by binding to the toxin molecules and rendering them inactive, preventing them from causing harm to the body. Antitoxins can be produced naturally by the immune system during an infection, or they can be administered artificially through immunization or passive immunotherapy. In a medical context, antitoxins are often used as a treatment for certain types of bacterial infections, such as diphtheria and botulism, to help counteract the effects of the toxins produced by the bacteria.

The oculomotor muscles are a group of extraocular muscles that control the movements of the eye. They include:

1. Superior rectus: This muscle is responsible for elevating the eye and helping with inward rotation (intorsion) when looking downwards.
2. Inferior rectus: It depresses the eye and helps with outward rotation (extorsion) when looking upwards.
3. Medial rectus: This muscle adducts, or moves, the eye towards the midline of the face.
4. Inferior oblique: The inferior oblique muscle intorts and elevates the eye.
5. Superior oblique: It extorts and depresses the eye.

These muscles work together to allow for smooth and precise movements of the eyes, enabling tasks such as tracking moving objects, reading, and maintaining visual fixation on a single point in space.

Overactive bladder (OAB) is a urological condition characterized by the involuntary contraction of the detrusor muscle of the urinary bladder, leading to symptoms such as urgency, frequency, and nocturia (the need to wake up at night to urinate), with or without urge incontinence (the involuntary loss of urine associated with a strong desire to void). It is important to note that OAB is not necessarily related to bladder volume or age-related changes, and it can significantly impact an individual's quality of life. The exact cause of OAB is not fully understood, but it may be associated with neurological disorders, certain medications, infections, or other underlying medical conditions. Treatment options for OAB include behavioral modifications, pelvic floor exercises, bladder training, medications, and, in some cases, surgical interventions.

Equinus deformity is a condition in which the ankle remains in a permanently plantarflexed position, meaning that the toes are pointing downward. This limitation in motion can occur in one or both feet and can be congenital (present at birth) or acquired. Acquired equinus deformity can result from conditions such as cerebral palsy, stroke, trauma, or prolonged immobilization. The limited range of motion in the ankle can cause difficulty walking, pain, and abnormalities in gait. Treatment options for equinus deformity may include physical therapy, bracing, orthotic devices, or surgery.

'Clostridium botulinum type B' is a gram-positive, spore-forming anaerobic bacterium that produces botulinum neurotoxin type B. This toxin is one of the seven types of botulinum neurotoxins (A-G) produced by various strains of Clostridium botulinum and related species. Botulinum neurotoxin type B is responsible for causing botulism, a rare but serious illness that affects the nervous system and can cause paralysis and even be fatal. The bacterium is commonly found in soil and water and can produce spores that are resistant to heat, which allows them to survive in adverse conditions. Botulinum neurotoxin type B is also used in medical treatments for various neurological disorders, such as cervical dystonia, blepharospasm, and chronic migraine, under the brand name Myobloc or NeuroBloc.

Mastication is the medical term for the process of chewing food. It's the first step in digestion, where food is broken down into smaller pieces by the teeth, making it easier to swallow and further digest. The act of mastication involves not only the physical grinding and tearing of food by the teeth but also the mixing of the food with saliva, which contains enzymes that begin to break down carbohydrates. This process helps to enhance the efficiency of digestion and nutrient absorption in the subsequent stages of the digestive process.

Rejuvenation, in the context of medicine and aesthetics, refers to the process or procedures aimed at restoring a youthful appearance or vitality. This can be achieved through various treatments such as hormone replacement therapy, cosmetic surgery, skin treatments, and lifestyle changes. However, it is important to note that while these procedures can help improve one's appearance or vitality, they do not halt the aging process entirely.

Skin aging, also known as cutaneous aging, is a complex and multifactorial process characterized by various visible changes in the skin's appearance and function. It can be divided into two main types: intrinsic (chronological or natural) aging and extrinsic (environmental) aging.

Intrinsic aging is a genetically determined and time-dependent process that results from internal factors such as cellular metabolism, hormonal changes, and genetic predisposition. The primary features of intrinsic aging include gradual thinning of the epidermis and dermis, decreased collagen and elastin production, reduced skin cell turnover, and impaired wound healing. Clinically, these changes present as fine wrinkles, dryness, loss of elasticity, and increased fragility of the skin.

Extrinsic aging, on the other hand, is caused by external factors such as ultraviolet (UV) radiation, pollution, smoking, alcohol consumption, and poor nutrition. Exposure to these environmental elements leads to oxidative stress, inflammation, and DNA damage, which accelerate the aging process. The main features of extrinsic aging are coarse wrinkles, pigmentary changes (e.g., age spots, melasma), irregular texture, skin laxity, and increased risk of developing skin cancers.

It is important to note that intrinsic and extrinsic aging processes often interact and contribute to the overall appearance of aged skin. A comprehensive approach to skincare should address both types of aging to maintain healthy and youthful-looking skin.

A deciduous tooth, also known as a baby tooth or primary tooth, is a type of temporary tooth that humans and some other mammals develop during childhood. They are called "deciduous" because they are eventually shed and replaced by permanent teeth, much like how leaves on a deciduous tree fall off and are replaced by new growth.

Deciduous teeth begin to form in the womb and start to erupt through the gums when a child is around six months old. By the time a child reaches age three, they typically have a full set of 20 deciduous teeth, including incisors, canines, and molars. These teeth are smaller and less durable than permanent teeth, but they serve important functions such as helping children chew food properly, speak clearly, and maintain space in the jaw for the permanent teeth to grow into.

Deciduous teeth usually begin to fall out around age six or seven, starting with the lower central incisors. This process continues until all of the deciduous teeth have been shed, typically by age 12 or 13. At this point, the permanent teeth will have grown in and taken their place, with the exception of the wisdom teeth, which may not erupt until later in adolescence or early adulthood.

Electromyography (EMG) is a medical diagnostic procedure that measures the electrical activity of skeletal muscles during contraction and at rest. It involves inserting a thin needle electrode into the muscle to record the electrical signals generated by the muscle fibers. These signals are then displayed on an oscilloscope and may be heard through a speaker.

EMG can help diagnose various neuromuscular disorders, such as muscle weakness, numbness, or pain, and can distinguish between muscle and nerve disorders. It is often used in conjunction with other diagnostic tests, such as nerve conduction studies, to provide a comprehensive evaluation of the nervous system.

EMG is typically performed by a neurologist or a physiatrist, and the procedure may cause some discomfort or pain, although this is usually minimal. The results of an EMG can help guide treatment decisions and monitor the progression of neuromuscular conditions over time.

Cosmetic techniques refer to medical or surgical procedures that are performed with the primary goal of improving the appearance or aesthetics of an individual. These techniques can be non-invasive, minimally invasive, or surgical in nature and may involve various treatments such as:

1. Botulinum toxin (Botox) injections: used to reduce wrinkles and fine lines by temporarily paralyzing the underlying muscles.
2. Dermal fillers: injected beneath the skin to add volume, smooth out wrinkles, and enhance facial features.
3. Chemical peels: a chemical solution is applied to the skin to remove damaged outer layers, revealing smoother, more even-toned skin.
4. Microdermabrasion: a minimally abrasive procedure that uses fine crystals or diamond tips to exfoliate and remove dead skin cells, resulting in a refreshed appearance.
5. Laser resurfacing: using laser technology to improve the texture, tone, and overall appearance of the skin by removing damaged layers and stimulating collagen production.
6. Micro-needling: a minimally invasive treatment that involves puncturing the skin with fine needles to promote collagen production and skin rejuvenation.
7. Facelift surgery (rhytidectomy): a surgical procedure that tightens loose or sagging skin on the face and neck, restoring a more youthful appearance.
8. Blepharoplasty: cosmetic eyelid surgery that removes excess fat, muscle, and skin from the upper and/or lower eyelids to improve the appearance of tired or aging eyes.
9. Rhinoplasty: nose reshaping surgery that can correct various aesthetic concerns such as a bulbous tip, crooked bridge, or wide nostrils.
10. Breast augmentation: surgical enhancement of the breasts using implants or fat transfer to increase size, improve symmetry, or restore volume lost due to aging, pregnancy, or weight loss.
11. Liposuction: a surgical procedure that removes excess fat from various areas of the body, such as the abdomen, hips, thighs, and arms, to contour and shape the body.

These cosmetic techniques aim to enhance an individual's appearance, boost self-confidence, and help them feel more comfortable in their own skin.

Toxoids are inactivated bacterial toxins that have lost their toxicity but retain their antigenicity. They are often used in vaccines to stimulate an immune response and provide protection against certain diseases without causing the harmful effects associated with the active toxin. The process of converting a toxin into a toxoid is called detoxication, which is typically achieved through chemical or heat treatment.

One example of a toxoid-based vaccine is the diphtheria and tetanus toxoids (DT) or diphtheria, tetanus, and pertussis toxoids (DTaP or TdaP) vaccines. These vaccines contain inactivated forms of the diphtheria and tetanus toxins, as well as inactivated pertussis toxin in the case of DTaP or TdaP vaccines. By exposing the immune system to these toxoids, the body learns to recognize and mount a response against the actual toxins produced by the bacteria, thereby providing immunity and protection against the diseases they cause.

'Clostridium botulinum type F' is a gram-positive, spore-forming anaerobic bacterium that produces a powerful neurotoxin known as botulinum toxin type F. This toxin is one of the seven types of botulinum toxins (A-G) produced by various strains of Clostridium botulinum and related species. The botulinum toxin type F causes a rare form of botulism, known as foodborne or wound botulism, which can lead to muscle paralysis and respiratory failure if left untreated. This bacterium and its toxin are classified as tier 1 select agents due to their high potential for misuse as bioterrorism agents.

The neuromuscular junction (NMJ) is the specialized synapse or chemical communication point, where the motor neuron's nerve terminal (presynaptic element) meets the muscle fiber's motor end plate (postsynaptic element). This junction plays a crucial role in controlling muscle contraction and relaxation.

At the NMJ, the neurotransmitter acetylcholine is released from the presynaptic nerve terminal into the synaptic cleft, following an action potential. Acetylcholine then binds to nicotinic acetylcholine receptors on the postsynaptic membrane of the muscle fiber, leading to the generation of an end-plate potential. If sufficient end-plate potentials are generated and summate, they will trigger an action potential in the muscle fiber, ultimately causing muscle contraction.

Dysfunction at the neuromuscular junction can result in various neuromuscular disorders, such as myasthenia gravis, where autoantibodies attack acetylcholine receptors, leading to muscle weakness and fatigue.

The temporomandibular joint (TMJ) is the articulation between the mandible (lower jaw) and the temporal bone of the skull. It's a complex joint that involves the movement of two bones, several muscles, and various ligaments. The TMJ allows for movements like rotation and translation, enabling us to open and close our mouth, chew, speak, and yawn. Dysfunction in this joint can lead to temporomandibular joint disorders (TMD), which can cause pain, discomfort, and limited jaw movement.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Paralysis is a loss of muscle function in part or all of your body. It can be localized, affecting only one specific area, or generalized, impacting multiple areas or even the entire body. Paralysis often occurs when something goes wrong with the way messages pass between your brain and muscles. In most cases, paralysis is caused by damage to the nervous system, especially the spinal cord. Other causes include stroke, trauma, infections, and various neurological disorders.

It's important to note that paralysis doesn't always mean a total loss of movement or feeling. Sometimes, it may just cause weakness or numbness in the affected area. The severity and extent of paralysis depend on the underlying cause and the location of the damage in the nervous system.

Clostridium botulinum type D is a gram-positive, spore-forming bacterium that produces a potent neurotoxin known as botulinum toxin type D. This toxin is one of the seven types of botulinum toxins (A-G) produced by various strains of Clostridium botulinum and related species. The bacteria and their toxins are the causative agents of botulism, a rare but serious illness that affects the nervous system and can cause paralysis and death if left untreated.

Botulinum toxin type D is particularly associated with cases of animal botulism, such as those observed in cattle and birds. It has also been studied for its potential therapeutic uses, including its ability to block the release of acetylcholine at the neuromuscular junction, which can be useful in treating various medical conditions characterized by muscle spasticity or excessive secretion. However, the use of botulinum toxin type D in humans is not widely approved or practiced due to its lower potency and shorter duration of action compared to other types of botulinum toxins.

Neuromuscular blocking agents (NMBAs) are a class of drugs that act on the neuromuscular junction, the site where nerve impulses transmit signals to muscles to cause contraction. NMBAs prevent the transmission of these signals, leading to muscle paralysis. They are used in medical settings during surgical procedures and mechanical ventilation to facilitate intubation, control ventilation, and prevent patient movement. It is important to note that NMBAs do not have any effect on consciousness or pain perception; therefore, they are always used in conjunction with anesthetics and analgesics.

NMBAs can be classified into two main categories based on their mechanism of action:

1. Depolarizing Neuromuscular Blocking Agents: These drugs, such as succinylcholine, cause muscle fasciculations (brief, involuntary contractions) before inducing paralysis. They work by binding to the acetylcholine receptors at the neuromuscular junction and depolarizing the membrane, which results in muscle paralysis. However, the continuous depolarization also causes desensitization of the receptors, leading to a loss of effectiveness over time. Depolarizing NMBAs have a relatively short duration of action.
2. Non-depolarizing Neuromuscular Blocking Agents: These drugs, such as rocuronium, vecuronium, and pancuronium, do not cause muscle fasciculations. They work by binding to the acetylcholine receptors at the neuromuscular junction without depolarizing the membrane, which prevents the transmission of nerve impulses to muscles and leads to paralysis. Non-depolarizing NMBAs have a longer duration of action compared to depolarizing NMBAs.

Close monitoring of neuromuscular function is essential when using NMBAs to ensure adequate reversal of their effects before the patient regains consciousness. This can be achieved through the use of nerve stimulators, which assess the degree of blockade and help guide the administration of reversal agents when necessary.

"Intralesional injection" is a medical term that refers to the administration of a medication directly into a lesion or skin abnormality, such as a tumor, cyst, or blister. This technique is used to deliver the medication directly to the site of action, allowing for higher local concentrations and potentially reducing systemic side effects. Common examples include the injection of corticosteroids into inflamed tissues to reduce swelling and pain, or the injection of chemotherapeutic agents directly into tumors to shrink them.

Marine toxins are toxic compounds that are produced by certain marine organisms, including algae, bacteria, and various marine animals such as shellfish, jellyfish, and snails. These toxins can cause a range of illnesses and symptoms in humans who consume contaminated seafood or come into direct contact with the toxin-producing organisms. Some of the most well-known marine toxins include:

1. Saxitoxin: Produced by certain types of algae, saxitoxin can cause paralytic shellfish poisoning (PSP) in humans who consume contaminated shellfish. Symptoms of PSP include tingling and numbness of the lips, tongue, and fingers, followed by muscle weakness, paralysis, and in severe cases, respiratory failure.
2. Domoic acid: Produced by certain types of algae, domoic acid can cause amnesic shellfish poisoning (ASP) in humans who consume contaminated shellfish. Symptoms of ASP include nausea, vomiting, diarrhea, abdominal cramps, headache, and memory loss.
3. Okadaic acid: Produced by certain types of algae, okadaic acid can cause diarrhetic shellfish poisoning (DSP) in humans who consume contaminated shellfish. Symptoms of DSP include nausea, vomiting, diarrhea, abdominal cramps, and fever.
4. Ciguatoxin: Produced by certain types of dinoflagellates, ciguatoxin can cause ciguatera fish poisoning (CFP) in humans who consume contaminated fish. Symptoms of CFP include nausea, vomiting, diarrhea, abdominal pain, and neurological symptoms such as tingling and numbness of the lips, tongue, and fingers, as well as reversal of hot and cold sensations.
5. Tetrodotoxin: Found in certain types of pufferfish, tetrodotoxin can cause a severe form of food poisoning known as pufferfish poisoning or fugu poisoning. Symptoms of tetrodotoxin poisoning include numbness of the lips and tongue, difficulty speaking, muscle weakness, paralysis, and respiratory failure.

Prevention measures for these types of seafood poisoning include avoiding consumption of fish and shellfish that are known to be associated with these toxins, as well as cooking and preparing seafood properly before eating it. Additionally, monitoring programs have been established in many countries to monitor the levels of these toxins in seafood and issue warnings when necessary.

No FAQ available that match "botulinum toxin bruxism"

No images available that match "botulinum toxin bruxism"